Advertisement

Endometrial factor testing is a useful tool in clinical infertility management

  • Carlos Simon
    Correspondence
    Corresponding author.
    Affiliations
    Igenomix Foundation-INCLIVA, Valencia, Spain

    Department of Pediatrics, Obstetrics & Gynecology, School of Medicine, Valencia University, Valencia, Spain

    Department of Obstetrics and Gynecology, BIDMC Harvard University, Boston, MA, USA
    Search for articles by this author
Published:December 25, 2021DOI:https://doi.org/10.1016/j.rbmo.2021.12.014

      Abstract

      Progress in medicine depends on new technologies and countercurrent concepts that translate to practice to solve long-standing problems. Application of transcriptomics to endometrial biology enables objective identification of the personalized period during which the maternal endometrium is receptive to an embryo, known as the window of implantation. Likewise, 16S rRNA gene sequencing of microorganisms allows identification of commensal microbes colonizing the endometrium linking their composition with reproductive outcomes in patients undergoing in vitro fertilization. Together, this knowledge underscores the clinical implication of endometrial factor testing for personalizing reproductive care. With such exciting developments and more to come, the era of generalized medicine for the endometrial factor will come to an end and will be replaced by individualized care to improve outcomes.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Reproductive BioMedicine Online
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect